Mutagenesis and carcinogenesis by nitropyrenes and cancer chemotherapeutics. Meeting report.
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000328:Adult; D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000633:toxicity*; D002460:Cell Line; D002648:Child; D006224:Cricetinae; D003412:Cricetulus; D004260:DNA Repair; D004781:Environmental Exposure; D005260:Female; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D009152:Mutagenicity Tests; D009374:Neoplasms, Experimental / Q000139:chemically induced; D009378:Neoplasms, Multiple Primary / Q000139:chemically induced; D009574:Nitro Compounds / Q000009:adverse effects / Q000633:toxicity*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011721:Pyrenes / Q000009:adverse effects / Q000633:toxicity*; D051381:Rats; D011916:Rats, Inbred F344; D012486:Salmonella typhimurium / Q000187:drug effects; D012854:Sister Chromatid Exchange / Q000187:drug effects
D000970:Antineoplastic Agents; D009574:Nitro Compounds; D011721:Pyrenes